"LymPro has completed two Phase 1 clinical studies
Post# of 30028
Posted On: 07/26/2014 10:23:03 AM
"LymPro has completed two Phase 1 clinical studies in over 80 patients, showing 98% sensitivity and 96% specificity for Alzheimer's disease diagnosis."
http://www.fiercemedicaldevices.com/press-rel...c-blood-te
If these are in-line with the numbers that Gerald will release this week the share price will hit the .40-.50 range. Global media will be all over LymPro.
Stay tuned for news.
"The trend is your friend but the science will make you rich."
Twitter: @AmarantusBio .... 10,000+ followers.
p.s. Buckle up!!!
http://www.fiercemedicaldevices.com/press-rel...c-blood-te
If these are in-line with the numbers that Gerald will release this week the share price will hit the .40-.50 range. Global media will be all over LymPro.
Stay tuned for news.
"The trend is your friend but the science will make you rich."
Twitter: @AmarantusBio .... 10,000+ followers.
p.s. Buckle up!!!
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼